n/a (FME.DE)
Le cours, les chiffres clés et les dernières actualités, au même endroit.
(FME.DE) : cours, analyse et données
Aucune donnée disponible
| Cours acheteur | 39.84 |
| Capitalisation boursière | 10.4B |
| Chiffre d’affaires (ttm) | n/a |
| Résultat net (ttm) | n/a |
| n/a | |
| 3.32 | |
| 11.75 | |
| n/a | |
| P/B (ttm) | n/a |
| P/S (ttm) | n/a |
| Date des résultats | n/a |
| Cours vendeur | 39.86 |
| Volume | 101,936 |
| Volume moy. (20D) | 863,476 |
| Ouverture | 40.36 |
| Clôture précédente | 40.13 |
| Fourchette du jour | 39.81 - 40.38 |
| Intervalle de 52 semaines | 34.57 - 47.86 |
| Analyste | n/a |
| Objectif de prix | n/a |
| Dividendes | n/a |
| Date ex-dividende | n/a |
À propos de FME.DE
A detailed description of the company is not yet available....
Profil complet de l’entrepriseSurprise sur les résultats
- Chiffre d’affaires de n/a est inférieur aux estimations de $0, avec NaN% croissance en glissement annuel.
- EPS de est inférieur aux estimations de , avec NaN% croissance en glissement annuel.
1 mois il y a · Simply Wall St.
Fresenius Medical Care (XTRA:FME) Expands BEACON US To Build Its Case For HVHDFFresenius Medical Care is expanding its BEACON-US clinical initiative to build real-world evidence for high-volume hemodiafiltration therapy in the U.S. The program evaluates the 5008X CAREsystem and ...
1 mois il y a · Simply Wall St.
Fresenius Medical Care (XTRA:FME) Stock Looks Like A Bargain Despite Weak ReturnsFresenius Medical Care stock has recovered modestly in the short term yet is still down about 30% over the past five years, while recent valuation checks suggest the market may be pricing it on the ch...
1 mois il y a · Simply Wall St.
Is Fresenius Medical Care (XTRA:FME) Undervalued Following Its New CEO Appointment?Fresenius Medical Care (XTRA:FME) has drawn fresh attention after the Supervisory Board appointed Cassie McLean as Management Board member and Chief Executive Officer of the Care Delivery segment, res...